FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans

DSpace/Manakin Repository

FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Leon, Doraliz en_US
dc.date.accessioned 2012-07-06T21:39:51Z
dc.date.issued 2003 en_US
dc.identifier.citation FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans (2003 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965598
dc.description.abstract This paper is a description of tissue-engineered products, their potential for replacing conventional approaches to missing or failing tissues and organs, and FDA’s ongoing efforts to develop a comprehensive and uniform scheme for regulating them. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject prosthetics en
dc.subject prosthesis en
dc.subject artificial organs en
dc.subject replacement parts en
dc.title FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T21:39:51Z

Files in this item

Files Size Format View
Ortizdeleon.pdf 204.9Kb PDF View/Open
Ortizdeleon.rtf 151.4Kb RTF file View/Open
Ortizdeleon.html 132.6Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters